06/23/2026
Earlier this month, BioCentury’s Grand Rounds U.S. conference brought biopharma leaders, investors, and researchers from across the country to Seattle for several days of discussion and collaboration focused on advancing translational science.
The event highlighted the exceptional science and innovation emerging from the Seattle region while creating valuable opportunities for local leaders to engage with potential partners and investors. Key conversations explored AI in healthcare, clinical trial efficiency, drug development, and the future of cell therapies.
As our life science ecosystem continues to grow, we look forward to welcoming more premier industry gatherings to Seattle and showcasing the innovation that positions our region as a leading life science hub. 🧬
Read more: https://alleninstitute.org/news/biocentury-grand-rounds-us-conference-highlights-importance-of-big-data